...
search icon
gnpx-img

Genprex Inc Share Price

GNPX
NAQ
$1.86
+$0.06
(3.33%)
1D
Industry: Biotechnology Sector: Health Care

Genprex Inc Analyst Forecast

Genprex Inc Share Price Chart

Genprex Inc Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$4.09M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0.0974
Volume info-icon
This is the total number of shares traded during the most recent trading day.
141.07K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
-0.80
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$1.71 L
$55 H
$1.86

About Genprex Inc, Common Stock

Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. The company's technologies are designed to administer disease-fighting genes to provide new therapies for patient populations with cancer and diabetes. Its oncology program utilizes its systemic, non-viral Oncoprex Delivery System, which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's lead product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC. Its three-lung cancer clinical programs have received a Fast Track Designation from the FDA for the treatment of that patient population, and SCLC program has received an FDA Orphan Drug Designation. The company's diabetes gene therapy comprises of a novel infusion process that uses an AAV vector to deliver Pdx1 and MafA genes directly to the pancreas. In models of Type 1 diabetes, its GPX-002 transforms alpha cells in the pancreas into functional beta-like cells, which produce insulin but distinct enough from beta cells to evade the body's immune system; and GPX-002 for Type 2 diabetes, where autoimmunity is not at play, is believed to rejuvenate and replenish exhausted beta cells. It has research agreement with The University of Michigan Rogel Cancer Center and Lung Cancer Study Collaboration with ALK Positive. Genprex, Inc. was incorporated in 2009 and is based in Austin, Texas. more

Industry: BiotechnologySector: Health Care

Genprex Inc Stock Returns

Time FrameGNPXSectorS&P500
1-Week Return-15.45%0.72%-1.31%
1-Month Return-34.04%1.27%0.78%
3-Month Return-49.59%3.13%3.46%
6-Month Return-80.51%15.81%6.19%
1-Year Return-90.93%8.89%11.68%
3-Year Return-99.94%20.79%71.21%
5-Year Return-99.98%35.89%74.81%
10-Year Return-99.98%138.44%256.59%

Genprex Inc Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Cost of Revenue22.78K22.53K25.57K15.00K6.69K[{"date":"2020-12-31","value":89.06,"profit":true},{"date":"2021-12-31","value":88.11,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":58.67,"profit":true},{"date":"2024-12-31","value":26.17,"profit":true}]
Gross Profit(22.78K)(22.53K)(25.57K)(15.00K)(6.69K)[{"date":"2020-12-31","value":-2277700,"profit":false},{"date":"2021-12-31","value":-2253400,"profit":false},{"date":"2022-12-31","value":-2557500,"profit":false},{"date":"2023-12-31","value":-1500400,"profit":false},{"date":"2024-12-31","value":-669300,"profit":false}]
Gross Margin-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Operating Expenses17.94M20.65M23.81M31.06M21.17M[{"date":"2020-12-31","value":57.75,"profit":true},{"date":"2021-12-31","value":66.48,"profit":true},{"date":"2022-12-31","value":76.64,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":68.15,"profit":true}]
Operating Income(17.96M)(20.67M)(23.83M)(31.08M)(21.17M)[{"date":"2020-12-31","value":-1796158100,"profit":false},{"date":"2021-12-31","value":-2067010200,"profit":false},{"date":"2022-12-31","value":-2383071900,"profit":false},{"date":"2023-12-31","value":-3107557000,"profit":false},{"date":"2024-12-31","value":-2117416700,"profit":false}]
Total Non-Operating Income/Expense37.62K10.27K180.20K446.12K126.58K[{"date":"2020-12-31","value":8.43,"profit":true},{"date":"2021-12-31","value":2.3,"profit":true},{"date":"2022-12-31","value":40.39,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":28.37,"profit":true}]
Pre-Tax Income(17.94M)(20.66M)(23.74M)(30.86M)(21.11M)[{"date":"2020-12-31","value":-1794277000,"profit":false},{"date":"2021-12-31","value":-2066496900,"profit":false},{"date":"2022-12-31","value":-2374062100,"profit":false},{"date":"2023-12-31","value":-3086046100,"profit":false},{"date":"2024-12-31","value":-2111116300,"profit":false}]
Income Taxes(18.81K)(5.13K)5.72M(4.00)(21.37B)[{"date":"2020-12-31","value":-0.33,"profit":false},{"date":"2021-12-31","value":-0.09,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":-373389.79,"profit":false}]
Income After Taxes(17.92M)(20.66M)(29.46M)(30.86M)21.35B[{"date":"2020-12-31","value":-0.08,"profit":false},{"date":"2021-12-31","value":-0.1,"profit":false},{"date":"2022-12-31","value":-0.14,"profit":false},{"date":"2023-12-31","value":-0.14,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Income From Continuous Operations(17.94M)(19.60M)(23.74M)(31.45M)(21.11M)[{"date":"2020-12-31","value":-1794277000,"profit":false},{"date":"2021-12-31","value":-1959562400,"profit":false},{"date":"2022-12-31","value":-2374062100,"profit":false},{"date":"2023-12-31","value":-3145480800,"profit":false},{"date":"2024-12-31","value":-2111116300,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(17.94M)(20.66M)(23.74M)(30.86M)(21.11M)[{"date":"2020-12-31","value":-1794277000,"profit":false},{"date":"2021-12-31","value":-2066496900,"profit":false},{"date":"2022-12-31","value":-2374062100,"profit":false},{"date":"2023-12-31","value":-3086046100,"profit":false},{"date":"2024-12-31","value":-2111116300,"profit":false}]
EPS (Diluted)(1.06)(0.41)(0.49)(4.43)(8.34)[{"date":"2020-12-31","value":-106,"profit":false},{"date":"2021-12-31","value":-41,"profit":false},{"date":"2022-12-31","value":-49,"profit":false},{"date":"2023-12-31","value":-443,"profit":false},{"date":"2024-12-31","value":-834.42,"profit":false}]

Genprex Inc Ratios

Genprex Inc Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

GNPX
Cash Ratio 0.43
Current Ratio 0.67

Genprex Inc Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

GNPX
ROA (LTM) -207.41%
ROE (LTM) -612.30%

Genprex Inc Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

GNPX
Debt Ratio Lower is generally better. Negative is bad. 0.78
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.22

Genprex Inc Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

GNPX
Trailing PE 0.10
Forward PE NM
P/S (TTM) 0.00
P/B 5.97
Price/FCF NM
EV/R 0.00
EV/Ebitda 0.18

FAQs

What is Genprex Inc share price today?

Genprex Inc (GNPX) share price today is $1.86

Can Indians buy Genprex Inc shares?

Yes, Indians can buy shares of Genprex Inc (GNPX) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in GNPX stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Genprex Inc be purchased?

Yes, you can purchase fractional shares of Genprex Inc (GNPX) via the Vested app. You can start investing in Genprex Inc (GNPX) with a minimum investment of $1.

How to invest in Genprex Inc shares from India?

You can invest in shares of Genprex Inc (GNPX) via Vested in three simple steps:

  • Click on Sign Up or Invest in GNPX stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Genprex Inc shares
What is Genprex Inc 52-week high and low stock price?

The 52-week high price of Genprex Inc (GNPX) is $55. The 52-week low price of Genprex Inc (GNPX) is $1.71.

What is Genprex Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Genprex Inc (GNPX) is 0.0974

What is Genprex Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Genprex Inc (GNPX) is 5.97

What is Genprex Inc dividend yield?

The dividend yield of Genprex Inc (GNPX) is 0.00%

What is the Market Cap of Genprex Inc?

The market capitalization of Genprex Inc (GNPX) is $4.09M

What is Genprex Inc's stock symbol?

The stock symbol (or ticker) of Genprex Inc is GNPX

How Can Investors Use Genprex Inc Share Price Data for Long-Term Investment Decisions?

Consider the share price of Genprex Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Genprex Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Genprex Inc shares for Indian investors?

When investing in Genprex Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Genprex Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Genprex Inc share price with other stocks in the same sector?

Rather than merely checking the share price of Genprex Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Genprex Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top